1,3,4-oxadiazole derivatives as potential biological agents

Mini-Reviews in Medicinal Chemistry

Volumn 13, Issue 12, 2013, Pages 1725-1743

  Sun, Juan ^a   Makawana, Jigar A ^a   Zhu, Hai Liang ^a,b  

^a NANJING UNIVERSITY   (China)

^b SHANDONG UNIVERSITY OF TECHNOLOGY   (China)

Author keywords

1,3,4 oxadiazole; Anticancer; Antimicrobial; Antiviral; Bioactivities; Synthesis

Indexed keywords

1, 3, 4 OXADIAZOLE DERIVATIVE; 1,3,4 OXADIAZOL BENZENE ACETATE DERIVATIVE; 1,3,4 OXADIAZOL PYRIDAZINONE DERIVATIVE; 1,3,4 OXADIAZOLE 1,2,3 TRIAZOL DERIVATIVE; 1,3,4 OXADIAZOLE 1,4 BENZODIOXAN DERIVATIVE; 1,3,4 OXADIAZOLE 2 THIONE DERIVATIVE; 1,3,4 OXADIAZOLE 2,5 PHENYL DERIVATIVE; 1,3,4 OXADIAZOLE ADAMANTYL DERIVATIVE; 1,3,4 OXADIAZOLE BENZIMIDAZOLE DERIVATIVE; 1,3,4 OXADIAZOLE BETA CARBOLINES DERIVATIVE; 1,3,4 OXADIAZOLE CYANO DERIVATIVE; 1,3,4 OXADIAZOLE FATTY ACID DERIVATIVE; 1,3,4 OXADIAZOLE INDOLYL DERIVATIVE; 1,3,4 OXADIAZOLE PYRAZOLE DERIVATIVE; 1,3,4 OXADIAZOLE PYRIDYL DERIVATIVE; 1,3,4 OXADIAZOLE SULFONYL DERIVATIVE; 1,3,4 OXADIAZOLE TRIMETHOXYPHENYL DERIVATIVE; ANTIVIRUS AGENT; BIS 1,3,4 OXADIAZOLE DERIVATIVE; CARBENDAZIM; CARBOXYLIC ACID; CYCLOPHOSPHAMIDE; DIHETEROCYCLIC 1,3,4 OXADIAZOLE DERIVATIVE; FLUOROURACIL; HYDRAZINE; INTEGRASE INHIBITOR; POLYPHOSPHATE; THIOSEMICARBAZIDE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALIDAMYCIN DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIINFLAMMATORY ACTIVITY; ANTIMICROBIAL ACTIVITY; ANTINEOPLASTIC ACTIVITY; ANTIPROLIFERATIVE ACTIVITY; ANTIVIRAL ACTIVITY; APOPTOSIS; BIOLOGICAL ACTIVITY; CANCER CELL; CHEMICAL PHENOMENA; CHEMISTRY; CYCLIZATION; DRUG SELECTIVITY; DRUG SYNTHESIS; FUNGICIDAL ACTIVITY; HUMAN; HYDROGEN BOND; MOLECULAR DOCKING; NONHUMAN; PHARMACOPHORE; REVIEW; STAPHYLOCOCCUS; STRUCTURE ACTIVITY RELATION;

ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; ANTIVIRAL AGENTS; APOPTOSIS; BACTERIA; DNA VIRUSES; FUNGI; HIV-1; HUMANS; OXADIAZOLES; RNA VIRUSES;

EID: 84888071900     PISSN: 13895575     EISSN: 18755607     Source Type: Journal    
DOI: 10.2174/13895575113139990071     Document Type: Review

References (125)

1. Hua, W. T. Heterocylic Chemistry [M]. Beijing: Beijing university press, 1990. (in Chinese).
2. Yuan, K. J.; Xi, P. Organic heterocyclic chemical [M]. The first edition. People's Medical Publishing House. 1984, 1-2. (in Chinese).
3. Sun, J.; Zhu, H.; Yang, Z. M. Zhu, H. L. Synthesis, molecular modeling and biological evaluation of 2-aminom ethyl-5-(quinolin-2-yl)-1, 3, 4-oxadiazole-2(3H)-thione quinolone derivatives as novel anticancer agent. Eur. J. Med. Chem. 2013, 60, 23-28.
4. 2-isoxazoline derivatives and their pharmacological characterization as-adrenergic receptor antagonists. Bioorg. Med. Chem, 1998, 6, 401-408.
5. Mishra, A.; Jain, S. K.; Asthana, J. G. Synthesis of Some Isoxazole Derivatives for their Analgesic and Anti-Inflammatory Activities. Orient. J. Chem. 1998, 14, 151-152.
6. Sun, J.; Li, M. H.; Qian, S. S.; et al. Synthesis and antitumor activity of 1, 3, 4-oxadiazole possessing 1, 4-benzodioxan moiety as a novel class of potent methionine aminopeptidase type II inhibitors. Bioorg. Med. Chem. Lett. 2013, 23, 2876-2879.
7. Kang, Y. K.; Shin, K. J.; Yoo, K. H.; Seo, K. J.; Park, S. Y.; Kim, D. J.; Park, S. W. Synthesis and biological evaluation of novel 1-methylcarbapenems having a new moiety at C-2. Bioorg. Med. Chem. Lett, 1999, 9, 2385-2390.
8. Tully, W. R.; Gardner, C. R.; Gillespie, R. J.; Westwood, R. 2-(Oxadiazelyl)-and 2-(thiazolyl)imidazole[1, 2-a]pyrimidines as agonists and inverse agonists at benzodiazepine receptors. J. Med. Chem, 1991, 34, 2060-2067.
9. Chen, C. Y.; Senanayake, C. H.; Bill, T. J.; Larsen, R. D.; Verhoeven, T. R.; Reider, P. J. Improved Fischer Indole Reaction for the Preparation of N, N-Dimethyltryptamines: Synthesis of L-695, 894, a Potent 5-HT1D Receptor Agonist. J. Org. Chem, 1994, 59, 3738-3741.
10. Holla, B. S.; Gonsalves, R.; Shenoy, S. Synthesis and antibacterial studies of a new series of 1, 2-bis(1, 3, 4-oxadiazol-2-yl)ethanes and 1, 2-bis(4-amino-1, 2, 4-triazol-3-yl)ethanes. Eur. J. Med. Chem, 2000, 35, 267-271.
11. Crimmin, M. J.; O'Hanlon, P. J.; Rogers, N. H.; Walker, G. The chemistry of pseudomonic acid. Part 10. Preparation of heterocyclic derivatives. J. Chem. Soc. Perkin. Trans. 1989, 1, 2047-2056.
12. Laddi, U. V.; Desai, S. R.; Bennur, R. S.; Bennur, S. C. Some new 1, 3, 4-oxadiazoles as antimicrobial agents. Ind. J. Heterocycl. Chem. 2002, 11, 319-322.
13. Amir, M.; Shikaha, K. Synthesis and anti-inflammatory, analgesic, ulcergenic and lipid peroxidation activities of some new 2-[(2, 6-dichloroanilino) phenyl]acetic acid derivatives. Eur. J. Med. Chem, 2004, 39, 535-545.
14. Piatnitski, E.; Kiselyov, A.; Doody, J.; Hadari, Y.; Ouyang, S.; Chen, X. Anti-angiogenic compounds and their use in cancer treatment. PCT Int Appl. WO052280, 2004.
15. Sun, J.; Cao, N.; Zhang, X. M.; et al. Oxadiazole derivatives containing 1, 4-benzodioxan as potential immunosuppressive agents against RAW264. 7 cells. Bioorg. Med. Chem. 2011, 19, 4895-4902.
16. Schlecker, R.; Thieme, P. C. The synthesis of antihypertensive 3-(1, 3, 4-oxadiazol-2-yl) phenoxypropanolahines. Tetrahedron. 1988, 44, 3289-3294.
17. Vardan, S.; Mookherjee, S.; Eich, R. Effects of tiodazosin, a new antihypertensive, hemodynamics and clinical variables. Clin. Pharm. Ther. 1983, 34, 290-296.
18. Ogata, M.; Atobe, H.; Kushida, H.; Yamamoto, K. In vitro sensitivity of mycoplasmas isolated from various animals and sewage to antibiotics and nitrofurans. J. Antibiot. 1971, 24, 443-451.
19. Piatnitski, E.; Kiselyov, A.; Doody, J.; Hadari, Y.; Ouyang, S.; Chen, X. Anti-angiogenic compounds and their use in cancer treatment. PCT Int Appl. WO052280, 2004.
20. Baxendale, I. R.; Ley, S. V.; Martinelli, M. The rapid preparation of 2-aminosulfonamide-1, 3, 4-oxadiazoles ising polymer-supported reagents and microwave heating. Tetrahedron, 2005, 61, 5323-5349.
21. Brown, B. J.; Clemens, I. R.; Neesom, J. K. Diisopropylcarbodiimide: A novel reagent for the synthesis of 1, 3, 4-oxadiazoles on solidphase. Synlett. 2000, 1, 131-133.
22. Coppo, F. T.; Evans, K. A.; Graybill, T. L.; Burton, G. Efficient onepot preparation of 5-substituted-2-amino-1, 3, 4-oxadiazoles using resin-bound reagents. Tetrahedron Lett, 2004, 45, 3257-3260.
23. Brain, C. T.; Paul, J. M.; Loong, Y.; Oakley, P. J. Novel procedure for the synthesis of 1, 3, 4-oxadiazoles from 1, 2-diacylhydrazines using polymer-supported Burgess reagent under microwave conditions. Tetrahedron Lett, 1999, 40, 3275-3278.
24. Brain, C. T.; Brunton, S. A. Synthesis of 1, 3, 4-oxadiazoles using polymer-supported reagents. Synlett. 2001, 3, 382-384.
25. Tandon, V. K.; Chhor, R. B. An efficient one pot synthesis of 1, 3, 4-oxadiazoles. Synth. Commun, 2001, 31, 1727-1732.
26. Mashraqui, S. H.; Ghadigonkar, S. G.; Kenny, R. S. An Expeditious and Convenient One Pot Synthesis of 2, 5-Disubstituted-1, 3, 4-oxadiazoles. Synth. Commun, 2003, 33, 2541-2545.
27. Bentiss, F.; Lagrenée, M.; Barbry, D. Rapid synthesis of 2, 5-disunstituted 1, 3, 4-oxadiazoles under microwave irradiation. Synth. Commun, 2001, 31, 935-938.
28. Wang, T.; Sauer, D. R.; Djuric, S. W. A simple and efficient one step synthesis of 1, 3, 4-oxadiazoles utilizing polymer-supported reagents and microwave heating. Tetrahedron Lett, 2006, 47, 105-108.
29. Li, Y.; Liu, J.; Zhang, H. Q.; Yang, X. P.; Liu, Z. J. Stereoselective synthesis and fungicidal activities of (E)--(methoxyimino)-benzeneacetate derivatives containing 1, 3, 4-oxadiazole ring., Bioorg. Med. Chem. Lett, 2006, 16, 2278-2282.
30. Sahin, G.; Palaska, E.; Ekizolu, M.; Özalp, M. Synthesis and antimicrobial activity of some 1, 3, 4-oxadiazole derivaties. Il Farmaco, 2002. 57, 539-542.
31. Zhang, Z. Y.; Yang, K. X.; Zeng, F. L Studies on Acyl Thiosemicarbazides and Related Heterocycles ()-Synthesis of 1-isonicotinoyl-4-Aryl Thiosemicarbazides and Related Nitrogen, Sulfur, Oxygen 5-Membered Heterocycles. Chem. J. Chin. Univ. 1988, 9, 239-245. (in Chinese).
32. Liu, F. M.; Wang, B. L.; Zhang, Z. F. et al. Studies on 1-(2'-phenyl-1', 2', 3'-triazol-4'-formyl)-4-arylthiosemicarbazides and related heterocyclic compounds. Organic Chemistry. 2001, 21, 1126-1128. (in Chinese).
33. Al-Talib, M.; Tastoush, H.; Odeh, N. A Convenient Synthesis of Alkyl and Aryl Substituted Bis-1, 3, 4-oxadiazoles. Synth. Commun. 1990, 20, 1811-1817.
34. Feng, L.; Chen, Z. Light-emitting conjugated molecule containing 1, 3, 4-oxadiazole, carbazole and naphthalene unit. Spectrochica Acta Part. 2006, 63, 15-20.
35. Rigo, B.; Cauliez, P. Reaction of Hexamethyldisilazane with Diacylhydrazines: An Easy 1, 3, 4-Oxadiazole Synthesis. Synth. Commun. 1986, 16, 1665-1670.
36. Rigo, B.; Cauliez, P. Acid catalyzed cyclization of bis silyl diacylhydrazines: a new 1, 3, 4-oxadiazole synthesis. Synth. Commun. 1988, 18, 1247-1251.
37. Pan, J. X.; Zhang, S. B.; Gao, Z. H. Research on 2, 5-Diaryl Oxadiazoles. Chemical Journal of Chinese Universities, 1987, 8, 37-140. (in Chinese).
38. REn, Z. J.; Li, Y.; Li, J. Y. A new method of synthesis for 1, 3, 4-oxadiazoles from thiosemicarbazide and aromatic acids with PPA. Chem. Reagents (Beijing, China), 1997, 19, 381-387. (in Chinese).
39. Wang, S.; Li, Z. T.; Hua, W. T. Synthesis and characterization of fully conjugated Schiff base macrocycles containing 1, 3, 4-oxadiazole moiety. Synth. Commun, 2002, 32, 3339-3345.
40. Yang, R. Y.; Dai, L. X. Hypervalent iodine oxidation of Nacylhydrazones and N-phenylsemicarbazone: an efficient method for the synthesis of derivatives of 1, 3, 4-oxadiazoles and DETTA. 3-1, 3, 4-oxadiazolines. J. Org. Chem. 1993, 58, 3381-3383.
41. Verheyde, B.; Dahaen, W. Synthesis of Dendrimers Containing 1, 3, 4-Oxadiazoles. J. Org. Chem, 2001, 66, 4062-4064.
42. Rivera, N. R.; Balsells, J.; Hansen, K. B. Synthesis of 2-amino-5-substituted-1, 3, 4-oxadiazoles using 1, 3-dibromo-5, 5-dimethylhydantoin as oxidant. Tetrahedron Lett, 2006, 47, 4889-4891.
43. Liras, S.; Allen, M. P.; Segelstein, B. E. A Mild Method for the Preparation of 1, 3, 4-Oxadiazoles: Triflic Anhydride Promoted Cyclization of Diacylhydrazines. Synth. Commun, 2000, 30, 437-443.
44. Tandon, V. K.; Chhor, R. B. An efficient one pot synthesis of 1, 3, 4-oxadiazoles. Synth. Commun. 2001, 31, 1727-1732.
45. Lutun, S.; Hasiak, B.; Couturier, D. A New Synthesis Of 1, 3, 4-Oxadiazoles. Cyclization Of N. N'-Diacylhydrazeves Catalyzed By palladium(0). Synth. Commun. 1999, 29, 111-116.
46. Mogilaiah, K.; Reddy, R. P. Indian J. Chem. 2001, 40B, 619-621.
47. Huang, W. Q.; Hou, X.; Li, C. X.; He, B. L. Solid-phase synthesis of 2, 5-substituted-1, 3, 4-oxadiazole compound library. Ion Exch. Adsorpt, 1998, 14, 171-174. (in Chinese).
48. Brown, B. J.; Clemens, I. R.; Neesom, J. K. Diisopropylcarbodiimide: A novel reagent for the synthesis of 1, 3, 4-oxadiazoles on solidphase. Synlett. 2000, 1, 131-133.
49. Liu, Z. X.; Zhao, J. L.; Huang, X. Solid-phase synthesis of 1, 3, 4-oxadiazoline-5-thione derivatives from resin-bound acylhydrazines. Bioorg. Med. Chem. Lett. 2006, 16, 1828-1830.
50. Mavandadi, F.; Pilotti, Å. The impact of microwave-assisted organic synthesis in drug discovery. Drug Discovery Today, 2006, 11, 165-174.
51. Wathey, B.; Tierney, J.; Lidström, P.; Westman, J. The Impact of microwave-assisted organic chemistry on drug discovery. Drug Discovery Today, 2002, 7, 373-380.
52. Wang, X. C.; Li, Z.; Zhang, Z. H.; Da, Y. X. Synthesis of 2-(4-chlorobenzoylamido)-5-aryloxymethyl-1, 3, 4-oxadiazoles under microwave irradiation. Synth. Commun, 2001, 31, 1907-1911.
53. Wang, X. C.; Li, Z.; W, B. G.; Wei, B. G.; Yang, J. Y. Synthesis of 2-(4-methoxylphenyloxy-acetylamido)-5-aryloxymethyl-1, 3, 4-oxadizoles under microwave irradiation. Synth. Commun, 2002, 32, 1097-1103.
54. Oussaid, B.; Moeini, L.; Martin, B. et al. Improved synthesis of oxadiazoles under microwave irradiation. Synth. Commun. 1995, 25, 1451-1459.
55. Joshi, S.; Karnik, A. V. Facile conversion of acyldiithiocarbazinate salts to 1, 3, 4-oxadiazole derivatives under microwave irradiation. Synth. Commun. 2002, 32, 111-114.
56. Christopher, T. B.; Shirley, A. B. Synthesis of 1, 3, 4-Oxadiazoles Using Polymer-supported Reagents. Synlet. 2001, 382-384.
57. Christopher, T. B.; Jane, M. P.; Yvonne, L.; et al. Novel procedure for the synthesis of1, 3, 4-oxadiazoles from1, 2-diacylhydrazines using polymer supported Burgess reagent under microwave conditions. Tetrahedron Lett. 1999, 40, 3275-3278.
58. Wang, Y.; Sauer, D. R.; Djuric, S. W. A simple and efficient one step synthesis of benzoxazoles and benzimidazoles from carboxylic acids. Tetrahedron Lett. 2006, 47, 105-108.
59. Oussaid, B.; Berlan, J.; Soufiaoui, M.; et al. Improved synthesis of oxazoline under microwave irradiation. Synth. Commun. 1995, 25, 659-665.
60. Schildberg, M.; Debaerdemeker, T.; Friedrichsen, W. 2H-1, 3, 4-Oxadiazin-2-one. Eine neue Klasse heterocyclischer Verbindungen. Chem Ber, 1988, 121, 887-889.
61. Chai, B.; Cao, S.; Liu, H. D. Synthesis and insecticidal activity of neonicotinoids derivatives. Heterocyclic Communications, 2002, 8, 601-606.
62. Joshi, T. K.; Zaidi, M. G. H. 2-Amino-5-substituted phenoxy methyl-1, 3, 4-oxa/thiadiazole: novel wood preservatives against Gleophyllum straitum. Pestology, 2003, XXVII(5), 20-23.
63. Mansour, A. K.; Eid, M. M.; Khalil, N. S. Synthesis and Reactions of Some New Heterocyclic Carbohydrazides and Related Compounds as Potential Anticancer Agents. Molecules, 2003, 8, 744-755.
64. Burbuliene, M. M.; Udrenaite, E.; Gaidelis, P. et al. Reactions of 5-(2-dimethylamino-6-methyl-4--pyrimidinylsulfanylmethyl)-1, 3, 4-oxadiazole-2-thi one with carbon electrophiles. Polish J Chem, 2002, 76, 557-563.
65. Kadi, A. A.; El-Brollosy, N. R.; Al-Deeb, O. A.; Habib, E. E.; Ibrahim, T. M.; El-Emam, A. A. Synthesis, antimicrobial, and anti-inflammatory activities of novel 2-(1-adamantyl)-5-substituted-1, 3, 4-oxadiazoles and 2-(1-adamantylamino)-5-substituted-1, 3, 4-thiadiazoles. Eur. J. Med. Chem, 2007, 42, 235-242.
66. Rauf, A.; Sharma, S,; Gangal, S. One-pot synthesis, antibacterial and antifungal activities of novel 2, 5-disubstituted-1, 3, 4-oxadiazoles. Chin. Chem. Lett, 2008, 19, 5-8.
67. Feng, X. M.; Chen, R. Studies of nucleophilic addition reaction of 2-aroylamino-5-benzyl-1, 3, 4-thiadiazole with 4-dimethylaminobenzaldehyde. Chin J Org Chem. 1994, 14, 84-87.
68. Yu, D. T.; Macina, O. T.; Sircar, I.; et al. Oxadiazole antifungal agents [P]. US6277873. 2001-08-2l.
69. Boesch, R-2-Cyano-5-substituted-1, 3, 4-oxadiazoles and fungicidal compositions containing them [P]. US4212867. 1980-07-15.
70. Padmavathi, V.; Reddy, G. S.; Padmaja, A.; Kondaiah, P.; Ali-Shazia. Synthesis, antimicrobial and cytotoxic activities of 1, 3, 4-oxadiazoles, 1, 3, 4-thiadiazoles and1, 2, 4-triazoles. Eur. J. Med. Chem, 2009, 44, 2106-2112.
71. Wang, W. Y.; Zhao, W. G.; Li, Z. M. Syntheses of 1, 3, 4-thia(oxa) diazole-substituted pyrazole derivatives and their fungicidal activities. Chem Res Chinese U. 2004, 20, 543-547.
72. Chen, H. S.; Li, Z. G.; Han, Y. F. Synthesis and Fungicidal Activity against Rhizoctonia solani of 2-Alkyl(Alkylthio)-5-pyrazolyl-1, 3, 4-oxadiazoles(Thiadiazoles). J. Agric. Food Chem, 2000, 48, 5312-5315.
73. Yuan, D. K.; Li, Z. M.; Zhao, W. G.; Chen, H. S. Synthesis and Bioactivity of 2-Substituted amino-5-pyrazolyl-1, 3, 4-oxadiazoles. Chin. J. Appl. Chem, 2003, 20(7), 624-628. (in Chinese).
74. Hu, G. Q.; Xu, Q. J.; Liu, B.; Zhang, Z. Q.; Chen, B. Q.; Xu, Q. T.; Huang, W. L.; Zhang, H. B.; Huang, S. T. Synthesis and antibacterial activity of 2-(3-pyridyl)-5-{[(5-aryl-1, 3, 4-oxadiazol-2-yl]methylene] thio}-1, 3, 4-oxadiazoles. Acta Pharm. Sin. B, 2004, 39, 263-265. (in Chinese).
75. Khan, M. S. Y.; Chawla, G.; Mueed, M. A. Synthesis and biological activity of some isoniazid based 1, 3, 4-oxadiazole derivatives. Indian J. Chem, 2004, 43B, 1302-1305.
76. EI-masry, A. H.; Fahmy, H. H.; Ali Abdelwahed, S. H. Synthesis and Antimicrobial Activity of Some New Benzimidazole Derivatives. Molecules, 2000, 5, 1429-1438.
77. Ansari, K. F.; Lai, C. Synthesis, physicochemical properties and antimicrobial activity of some new benzimidazole derivatives. Eur. J. Med. Chem, 2009, 44, 4028-4033.
78. Maslat, A. O.; Abussaud, M.; Tashtoush, H.; AL-Talib, M. Synthesis, antibacterial, antifungal and genotoxic activity of Bis-1, 3, 4-oxadiazaole derivatives. Pol. J. Pharmacol, 2002, 54, 55-59.
79. Liu, Z. M.; Yang, G. F.; Qin, X. H. Synthesis and biological activities of novel diheterocyclic compounds containing 1, 2, 3-triazolo[1, 5-a]pyrimidine and 1, 3, 4-oxadiazole. J. Chem. Technol. Biotechnol. 2001, 1154-1158.
80. Farghaly, A. R. A. H. Synthesis, Reactions and Antimicrobial Activity of Some New Indolyl-1, 3, 4-Oxadiazole, Triazole and Pyrazole Derivatives. J. Chin. Chem. Society. 2004, 51, 147-156.
81. Zhang, Y.; Qiao, R. Z.; Xu, P. F.; et al. Synthesis and antibacterial activities of 2-(1-aryl-5-methyl-1, 2, 3-triazol-4-yl)-1, 3, 4-oxadiazole derivatives. J. Chin. Chem. Society. 2002, 49, 369-373.
82. Zou, X. J.; Zhang, Z. X.; Jin, G. Y. Synthesis and biological activity of 1, 3, 4-oxadiazole-substituted pyridazinones. J. Chem. Research (S). 2002, 228-230.
83. Li, Y; Liu, J; Zhang, H. Q.; Yang, X. P.; Liu, Z. J. Stereoselective synthesis and fungicidal activities of (E)--(methoxyimino)-benzeneacetate derivatives containing 1, 3, 4-oxadiazole ring. Bio. Med. Chem. Lett. 2006, 16, 2278-2282.
84. Seymour, L. Novel anti-cancer agents in development: exciting prospects and new challenges. Cancer Treat. Rev. 1999, 25, 301-312.
85. Zahid, M.; Yasin, K. A.; Akhtar, T.; Hameed, S.; Al-Masoudi, N. A.; Loddo, R.; La Colla, P. Synthesis and in vitro antiproliferative activity of new adamantyltiazolyl-1, 3, 4-oxadiazoles. ARKIVOC (Gainesville, FL, U. S.), 2009, XI, 85-93.
86. Jin, L. H.; Chen, J.; Song, B. A.; Chen, Z.; Yang, S.; Li, Q. Z.; Hu, D. Y.; Xu, R. Q. Synthesis, structure, and bioactivity of N'-substituted benzylidene-3, 4, 5-trimethoxybenzohydrazide and 3-acetyl-2-substituted phenyl-5-(3, 4, 5-trimethoxyphenyl)-2, 3-dihydro-1, 3, 4-oxadiazole derivatives. Bioorg. Med. Chem. Lett, 2006, 16, 5036-5040.
87. Zhang, X. M.; Qiu, M.; Sun, J.; Zhang, Y. B.; Yang, Y. S.; Wang, X. L.; Tang, J. F.; Zhu, H. L. Synthesis, biological evaluation, and molecular docking studies of 1, 3, 4-oxadiazole derivatives possessing 1, 4-benzodioxan moiety as potential anticancer agents. Bioorg. Med. Chem, 2011, 19, 6518-6524.
88. Kumar, A.; D'Souza, S.; Gaonkar, S. L.; Rai, K. M. L.; Salimath, B. P. Growth inhibition and induction of apoptosis in MCF-7 breast cancer cells by a new series of substituted-1, 3, 4-oxadiazole derivatives. Invest. New Drugs, 2008, 26, 425-435.
89. Sondhi, S. M.; Kumar, S.; Kumar, N.; Roy, P. Synthesis antiinflammatory and anticancer activity evaluation of some pyrazole and oxadiazole derivatives. Med. Chem. Res, 2012, 21, 3043-3052.
90. Zheng, Q. Z.; Zhang, X. M.; Xu, Y.; Cheng, K.; Jiao, Q. C.; Zhu, H. L. Synthesis, biological evaluation, and molecular docking studies of 2-chloropyridine derivatives possessing 1, 3, 4-oxadiazole moiety as potential antitumor agents. Bioorg. Med. Chem, 2010, 18, 7836-7841.
91. Kumar, A.; D'Souza, S. S.; Mysore Nagaraj, S. R.; Gaonkar, S. L.; Salimath, B. P.; Lokanatha Rai, K. M. Antiangiogenic and antiproliferative effects of substituted-1, 3, 4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1 in Ehrlich ascites tumor cells. Cencer Chemother. Pharmacol, 2009, 64, 1221-1233.
92. Aboraia, A. S.; Abdel-Rahman, H.; Mahfouz, N.; EL-Gendy, M. A. Novel 5-(2-hydroxyphenyl)-3-substituted-2, 3-dihydro-1, 3, 4-oxadiazole-2-thione derivatives: Promising anticancer agents. Bioorg. Med. Chem, 2006, 14, 1236-1246.
93. Savariz, F. C.; Formagio, A. S. N.; Barbosa, V. A.; Foglio, M. A.; Carvalho, J. E.; Duarte, M. C. T.; Dias Filho, B. P.; Sarragiotto, M. H. Synthesis, Antitumor and Antimicrobial Activity of Novel 1-Substituted Phenyl-3-[3-alkylamino(methyl)-2-thioxo-1, 3, 4-oxadiazol-5-yl]-Carboline Derivatives. J. Braz. Chem. Soc, 2010, 21, 288-298.
94. Akhtar, T.; Hameed, S.; Al-Masoudi, N.; Loddo, R.; Colla, P. In vitro antitumor and antiviral activities of new benzothiazole and 1, 3, 4-oxadiazole-2-thione derivatives. Acta Pharm, 2008, 58, 135-149.
95. Kumar, D.; Sundaree, W.; Johnson, E. O.; Shah, K. An efficient synthesis and biological study of novel inholyl-13, 4-oxadiazoles as potent anticancer agents. Bioorg. Med. Chem. Lett, 2009, 19, 4492-4494.
96. Nazari Formagia, A. S.; Düsman Tonin, L. T.; Foglio, M. A.; Madjarof, C.; Carvalho, J. E.; Costa, W. F.; Cardoso, F. P.; Sarragiotto, M. H. Synthesis and antitumoral activity of novel 3-(2-substituted-1, 3, 4-oxadiazol-5-yl) and 3-(5-substituted-1, 2, 4-triazol-3-yl)-carboline derivatives. Bioorg. Med. Chem, 2008, 16, 9660-9667.
97. Clercq, E. D.; Field, H. J. Antiviral prodrugs-the development of successful prodrug strategies for antiviral chemotherapy. Br. J. Pharmacol, 2006, 147, 1-11.
98. De Clercq, E. New developments in anti-HIV chemotherapy. Curr Med. Chem. 2001, 8, 1543-1572.
99. Clercq, E. D. New developments in anti-HIV chemotherapy. Biochim. Biophys. Acta, Mol. Basis Dis, 2002, 1587, 258-275.
100. Li, Z.; Zhan, P.; Liu, X. 1, 3, 4-Oxadiazole: A Privileged Structure in Antiviral Agents. Mini-Reviews in Medicinal Chemistry. 2011, 11, 1130-1142.
101. Barreiro, G.; Kim, J. T.; Guimar es, C. R. W.; Bailey, C. M; Domaoal, R. A.; Wang, L.; Anderson, K. S.; Jorgensen, W. L. From Docking False-Positive to Active Anti-HIV Agent. J. Med. Chem, 2007, 50, 5324-5329.
102. Jorgensen, W. L. Efficient Drug Lead Discovery and Optimization. Acc. Chem. Res, 2009, 42, 724-733.
103. Zeevaart, J. G.; Wang, L. G.; Thakur, V. V.; Leung, C. S.; Tirado-Rives, J.; Bailey, C. M.; Domaoal, R. A.; Anderson, K. S.; Jorgensen, W. L. Optimization of Azoles as Anti-Human Immunodeficiency Virus Agents Guided by Free-Energy Calculations. J. Am. Chem. Soc, 2008, 130, 9492-9499.
104. Silvestri, M. A.; Nagarajan, M.; Clercq, E. D.; Pannecouque, C.; Cushman, M. Design, Synthesis, Anti-HIV Activities, and Metabolic Stabilities of Alkenyldiarylmethane (ADAM) Nonnucleoside Reverse Transcriptase Inhibitors. J. Med. Chem, 2004, 47, 3149-3162.
105. Deng, B. L.; Hartman, T. L.; Buckheit, R. W.; Pannecouque, C.; Clercq, E. D.; Fanwick, P. E.; Cushman, H. Synthesis, Anti-HIV Activities, and Metabolic Stability of New Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors. J. Med. Chem, 2005, 48, 6140-6155.
106. Zhan, P.; Li, Z.; Liu, X. Cosalane and its Analogues: A Unique Class of Anti-HIV Agents. Mini. Rev. Med. Chem. 2010, 10, 966-976.
107. Cullen, M. D.; Ho, W. C.; Bauman, J. D.; Das, K.; Arnold, E.; Hartman, T. L.; Watson, K. M.; Buckheit, R. W., Jr.; Pannecouque, C.; Clercq, E. D.; Cushman, M. Crystallographic Study of a Novel Subnanomolar Inhibitor Provides Insight on the Binding Interactions of ALkenyldiarylmethanes with Human Immunodeficiency Virus-1 Reverse Transcriptase. J. Med. Chem, 2009, 52, 6467-6473.
108. Aquino, C. J.; Dickson, H.; Peat, A. J. Preparation of 1, 3, 4-oxadiazoles as a non-nucleoside reverse transcriptase inhibitor for treating human immunodeficiency virus infection. WO2008157330 A1, 2008.
109. Serrao, E.; Odde, S.; Ramkumar, K.; Neamati, N. Raltegravir, elvitegravir, and metoogravir: the birth of "me-too" HIV-1 integrase inhibitors. Retrovirology, 2009, 6-25.
110. Hombrouck, A.; Voet, A.; Van Remoortel, B.; Desadeleer, C.; De Maeyer, M.; Debyser, Z.; Witvrouw, M. Mutations in Human Immunodeficiency Virus Type 1 Integrase Confer Resistance to the Naphthyridine L-870, 810 and Cross-Resistance to the Clinical Trial Drug GS-9137. Antimicrob. Agents Chemother, 2008, 52, 2069-2078.
111. Sato, M.; Motomura, T.; Aramaki, H.; Matsuda, T.; Yamashita, M.; Ito, Y.; Kawakami, H.; Matsuzaki, Y.; Watanabe, W.; Yamataka, K.; Ikeda, S.; Kodama, E.; Matsuoka, M.; Shinkai, K. Novel HIV-1 Integrase Inhibitors Derives from Quinolone Antibiotics. J. Med. Chem, 2006, 49, 1506-1508.
112. Zeevaart, J. G.; Wang, L.; Thakur, V. V.; Leung, C. S.; Tirado-Rives, J.; Bailey, C. M.; Domaoal, R. A.; Anderson, K. S.; Jorgensen, W. L. Optimization of Azoles as Anti-Human Immunodeficiency Virus Agents Guided by Free-Energy Calculations. J. Am. Chem. Soc, 2008, 130, 9492-9499.
113. Lansdon, E. B.; Brendza, K. M.; Hung, M.; Wang, R.; Mukund, S.; Jin, D.; Birkus, G.; Kutty, N.; Liu, X. H. Crystal Structure of HIV-1 Reverse Transcriptase with Etravirine (TMC125) and Rilpivirine (TMC278): Implication for Drug Design. J. Med. Chem, 2010, 53, 4295-4299.
114. Cullen, M. D.; Deng, B. L.; Hartman, T. L.; Watson, K. M.; Buckheit, R. W.; Pannecouque, C.; Clercq, E. D.; Cushman, M. Synthesis and Biological Evaluation of Alkenyldiarylmethane HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors That Possess Increased Hydrolytic Stability. J. Med. Chem, 2007, 50, 4854-4867.
115. Johns, B. A.; Weatherhead, J. G.; Allen, S. H.; Thompson, J. B.; Garvey, E. P.; Foster, S. A.; Jeffrey, J. L.; Miller, W. H. The use of oxadiazole and triazole substituted naphthyridines as HIV-1 integrase inhibitors. Part 1: Establishing the pharmacophore. Bioorg. Med. Chem. Lett, 2009, 19, 1802-1806.
116. Kim, R. M.; Rouse, E. A.; Chapman, K. T.; Schlei, W. A.; Olsen, D. B.; Stahlhut, M.; Rutkowski, C. A.; Emini, E. A.; Tata, J. R. P1' oxadiazole protease inhibitors with excellent activity against native and protease inhibitor-resistant HIV-1. Bioorg. Med. Chem. Lett, 2004, 14, 4651-4654.
117. Zhang, F. Q.; Chapman, K. T.; Schleif, W. A.; Olsen, D. B.; Stahlbut, M.; Rutkowaski, C. A.; Kuo, L. C.; Jin, L. X.; Emini, E. A.; Tata, J. R. The design, synthesis and evaluation of novel HIV-1 protease inhibitors with high potency against PI-resistant viral strains. Bioorg. Med. Chem. Lett, 2003, 13, 2573-2576.
118. Duffy, J. L.; Kirk, B. A.; Kevin, N. J.; Chapman, K. T.; Schleif, W. A.; Olsen, D. B.; Stahlhut, M.; Rutkowski, C. A.; Kuo, L. C.; Jin, L. X.; Lin, J. H.; Emini, E. A.; Tata, J. R. HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1' substituent. Bioorg. Med. Chem. Lett, 2003, 13, 3323-3326.
119. EI-Emam, A.; AI-Deeb, O. A.; AI-Omar, M.; Lehmann, J. Synthesis, antimicrobial, and anti-HIV-1 activity of certain 5-(1-adamantyl)-2-substituted thio-1, 2, 4-oxadiazoles and 5-(1-adamantyl)-3-substituted aminomethyl-1, 3, 4-oxadiazoline-2-2thiones. Bioorg. Med. Chem, 2004, 12, 5107-5113.
120. Liverton, N. J.; Holloway, M. K.; McCauley, J. A.; Rudd, M. T.; Butcher, J. W.; Carroll, S. S.; DiMuzio, J.; Fandozzi, C.; Gilbert, F. K.; Mao, S. S.; Mclntyre, C. J.; Nguyen, K. T.; Romano, J. J.; Stahlhut, M.; Wan, B. L.; Olsen, D. B.; Vacca, J. P. Molecular Modeling Based Approach to Potent P2-P4 Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease. J. Am. Chem. Soc, 2008, 130, 4607-4609.
121. Di Francesco, M. E.; Dessole, G.; Nizi, E.; Pace, P.; Koch, U.; Fiore, F.; Pesci, S.; Di Muzio, J.; Monteagudo, E.; Rowley, M.; Summa, V. Novel Macrocyclic Inhibitors of Hepatitis C NS3/4A Protease Featuring a 2-Amino-1, 3-thiazole as a P4 Carbamate Replacement. J. Med. Chem, 2009, 52, 7014-7028.
122. Barradas, J. S.; Errea, M. I.; D'Accorso, N. B.; Seplúveda, C. S.; Talarico, L. B.; Damonte, E. B. Synthesis and antiviral activity of azoles obtained from carbohydrates. Carbohydr. Res, 2008, 343, 2468-2474.
123. Tan, T. M.; Chen, Y.; Kong, K. H.; Bai, J.; Li, Y.; Lim, S. G.; Lam, Y. Synthesis and the biological evaluation of 2-benzenesulfonylalkyl-5-substituted-sulfanyl-[1, 3, 4]-oxadiazoles as potential anti-hepatitis B birus agents. Antiviral Res, 2006, 71, 7-14.
124. Abdel-Aal, M. T.; El-Sayed, W. A.; El-Kosy, S. M.; El-Ashry el, S. H. Synthesis and Antiviral Evaluation of Novel 5-(N-Arylaminomethyl-1, 3, 4-oxadiazol-2-yl)hydrazines and Their Sugars, 1, 2, 4-Trizoles, Tetrazoles and Pryazolyl Dericatives. Arch. Phar. (Weinheim, Ger.), 2008, 341, 307-313.
125. Zhan, P.; Li, D.; Chen, X.; Liu, X.; De Clercq, E. Recent advances in DAPYs and related analogues as HIV-1 NNRTIs. Curr. Med. Chem. 2011, 18, 29-46.